The ROE (Return on Equity) of Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is 12.26%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2025-03-31 | 12.26% |
| 2024-03-31 | 15.74% |
| 2023-03-31 | 14.51% |
| 2022-03-31 | 16.02% |
| 2021-03-31 | 16.58% |
| 2020-03-31 | 16.43% |
| 2019-03-31 | 18.08% |
| 2018-03-31 | 15.44% |
| 2017-03-31 | 14.62% |
| 2016-03-31 | 16.49% |